Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals: a Randomized Controlled Trial Protocol

NCT07609160 is registered in ClinicalTrials.gov with Acibadem University as lead sponsor.

NCT NCT07609160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07609160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals: a Randomized Controlled Trial Protocol
Lead sponsor
Acibadem University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
January 1, 2028
Enrollment
108 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight (without type 2 diabetes) with weight-related comorbidities, sarcopenia